Liraglutide Explained: How It Works and Who It's For

Liraglutide at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2010
• Route: subcutaneous injection
• Typical frequency: once daily
• Half-life: approximately 13 hours
• Cash price (US): $1,200-$1,400/month without insurance
• Receptor target: GLP-1 receptor

Most people land on a Liraglutide page because they're weighing it against another option, trying to manage side effects, or trying to figure out if it's worth the money. We try to answer all three honestly here. The headline: Average weight loss of 5-8% of body weight at one year in clinical trials, with additional A1c reductions of 1.0-1.5% in people with type 2 diabetes.

What is Liraglutide?

Liraglutide is a once-daily GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1. It slows gastric emptying, increases satiety through receptors in the hypothalamus, and stimulates glucose-dependent insulin secretion from pancreatic beta cells.

Liraglutide is manufactured by Novo Nordisk. Liraglutide was approved by the FDA in 2010. Its approved indications include type 2 diabetes (Victoza), chronic weight management (Saxenda). Off-label use happens in clinical practice but is the prescriber's responsibility.

The drug class glp-1 receptor agonist works by acting at the GLP-1 receptor. Here's what to expect.

How Liraglutide Works in the Body

Liraglutide is a once-daily GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1. It slows gastric emptying, increases satiety through receptors in the hypothalamus, and stimulates glucose-dependent insulin secretion from pancreatic beta cells. The receptor target — GLP-1 receptor — drives the downstream effects users care about: average weight loss of 5-8% of body weight at one year in clinical trials, with additional a1c reductions of 1.0-1.5% in people with type 2 diabetes.

The pharmacokinetics matter for daily use. Liraglutide has a half-life of approximately 13 hours, which determines how often it is dosed. The standard route of administration is subcutaneous injection, and the typical schedule is once daily.

For more detail on the underlying biology, see our breakdown of how Liraglutide works.

Who Uses Liraglutide?

Liraglutide is most relevant for people whose situation maps to its approved indications: type 2 diabetes (Victoza); chronic weight management (Saxenda).

People who should avoid Liraglutide include those with the following:

• personal or family history of medullary thyroid carcinoma
• MEN 2 syndrome
• prior serious hypersensitivity

Common and Serious Side Effects

The most commonly reported side effects of Liraglutide include:

• nausea
• diarrhea
• constipation
• vomiting
• headache
• injection-site reactions

Serious risks — uncommon but worth knowing — include:

• pancreatitis
• gallbladder disease
• thyroid C-cell tumors (boxed warning)
• acute kidney injury from dehydration

We have a more detailed breakdown in our Liraglutide side-effects guide.

Liraglutide vs Alternatives

Common alternatives include semaglutide (more potent, weekly dosing), tirzepatide (dual GIP/GLP-1, greater weight loss), and dulaglutide (weekly dosing). If you are weighing Liraglutide against another option, our comparison pages include Liraglutide Side Effects: The Complete List and How to Handle Them, Real Liraglutide Results: What 6 and 12 Months Actually Look Like, The Real Liraglutide Price Tag in 2026 — With and Without Insurance.

Bottom Line

Treat Liraglutide as one tool among several. The most successful users we see treat it as part of a structured approach, not a standalone fix. Multiple randomized controlled trials support its efficacy. If you are considering Liraglutide, talk to a licensed clinician first — particularly if you take other medications.

Frequently Asked Questions

Related Reading

• Liraglutide Side Effects: The Complete List and How to Handle Them
• Real Liraglutide Results: What 6 and 12 Months Actually Look Like
• The Real Liraglutide Price Tag in 2026 — With and Without Insurance
• Using Liraglutide for Weight Loss: A Practical Patient Guide
• Dulaglutide Explained: How It Works and Who It's For
• What Is Exenatide? Everything You Should Know Before Starting

Sources

• Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). NEJM 2015;373:11.
• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.
• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.

This page is informational only and is not medical advice. Consult a licensed clinician before starting, stopping, or changing any medication.